GARY A. LYONS - 01 Feb 2022 Form 4 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role
Director
Signature
/s/ Gary A. Lyons
Issuer symbol
ELDN
Transactions as of
01 Feb 2022
Net transactions value
$0
Form type
4
Filing time
02 Feb 2022, 16:33:31 UTC
Previous filing
12 Oct 2021
Next filing
27 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELDN Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 01 Feb 2022 Common Stock 20,000 $3.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase up to 20,000 shares of Common Stock, which option vests with respect to 100% of the total number of shares on 2/1/2023.